ARCHIVES

In Brief: Magnuson Delays Action On Apparitions Bill; No Vote See Now Until September

This article is from The Cancer Letter archive.

Vol. 04 No. 30 | July 28, 1978

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

ONCC Says 1,480 Nurses Passed Certification Exam

January 6, 1989

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

In Brief: Schilsky Succeeds McIntyre As CALB Chair; UC Irvine Awarded New Cancer Center Grants

November 11, 1994